Ipca Laboratories (IPCALAB) | Stock Overview & Key Data
Ipca Laboratories Performance Comparison
Stock Range
Today's Range
Low: ₹1,309.00
High: ₹1,347.90
on September 18, 2025
52 Week Range
Low: ₹1,168.20
High: ₹1,755.90
on April 7, 2025
on January 7, 2025
All-Time High: ₹1,755.90 on January 6, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR332.7B
EPS
30.63
P/E Ratio (TTM)
42.78
Forward P/E
27.38
P/B Ratio
4.78
PEG Ratio
2.01
Div. Yield
0.42%
ROE
8.79%
Beta
0.157
Debt to Equity
16.25
Financial Highlights
Profitability
Gross Margin
70.05%
Operating Margin
13.70%
Profit Margin
8.50%
Returns and Earnings
Return on Assets (TTM)
6.27%
Return on Equity (TTM)
8.79%
EBITDA
INR18.6B
Net Income (TTM)
INR7.8B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR360.95
Quarterly Revenue Growth (YoY)
10.30%
Quarterly Earnings Growth (YoY)
21.30%
Dividend Information
Last 12-Month Dividend
₹6.00
Current Dividend Yield
0.42%
3-Year Average Dividend Yield
0.21%
3-Year Average Annual Dividend
₹4.00
3-Year Total Dividends
₹12.00
Ex-Dividend Date
August 5, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Ipca Laboratories IPCALAB | 332.75B Large-cap | -0.14% | -5.25% | -3.52% | -0.49% | -22.55% | -8.60% | 50.03% | 26.86% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 1.68% | -0.77% | -1.82% | -4.93% | -14.27% | -13.16% | 75.90% | 230.89% |
| Divi's Laboratories DIVISLAB | 1.62T Large-cap | 0.33% | -1.83% | -7.44% | 6.71% | -0.35% | 11.02% | 66.13% | 97.71% |
| Cipla CIPLA | 1.26T Large-cap | -0.24% | -0.33% | 3.76% | 4.52% | 5.45% | 8.37% | 46.05% | 102.57% |
| Torrent TORNTPHARM | 1.21T Large-cap | -1.21% | -2.83% | 9.00% | 15.72% | 3.80% | 2.62% | 134.03% | 30.49% |
| Dr. Reddy's DRREDDY | 1.09T Large-cap | 0.55% | 3.86% | -0.56% | 13.97% | -4.21% | 0.09% | 58.41% | 28.26% |
Ownership & Short Interest
Insider Ownership
45.05%
Institutional Ownership
43.55%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
134K
Average 90-Day Volume
157K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IPCALAB's 52-week high and low?
- In the last 52 weeks, Ipca Laboratories reached a high of ₹1,755.90 (on January 7, 2025) and a low of ₹1,168.20 (on April 7, 2025).
- What is the market cap and P/E ratio for IPCALAB?
- Curious about Ipca Laboratories's size and valuation? Its market capitalization stands at 332.75B. When it comes to valuation, the P/E ratio (trailing twelve months) is 42.78, and the forward P/E (looking ahead) is 27.38.
- Does IPCALAB pay dividends? If so, what's the yield?
- Yes, Ipca Laboratories is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.42%, and the company has paid an average of ₹4.00 per share annually over the past 3 years.
- Who are Ipca Laboratories's main competitors or similar companies to consider before investing?
When looking at Ipca Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -13.16% 75.90% Divi's Laboratories
DIVISLAB1.62T Healthcare Drug Manufacturers - Specialty & Generic 11.02% 66.13% Cipla
CIPLA1.26T Healthcare Drug Manufacturers - Specialty & Generic 8.37% 46.05% Torrent
TORNTPHARM1.21T Healthcare Drug Manufacturers - Specialty & Generic 2.62% 134.03% Dr. Reddy's
DRREDDY1.09T Healthcare Drug Manufacturers - Specialty & Generic 0.09% 58.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ipca Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Ipca Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.79%, the Debt to Equity ratio from the most recent quarter is 16.25, and its Gross Profit Margin stands at 70.05%.
- What is the recent revenue and earnings growth for IPCALAB?
- Looking at Ipca Laboratories's growth, its revenue over the trailing twelve months (TTM) was INR92B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.30%, and quarterly earnings saw a YoY growth of 21.30%.
- How much of IPCALAB stock is held by insiders and institutions?
- Wondering who owns Ipca Laboratories stock? Company insiders (like executives and directors) hold about 45.05% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 43.55%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.